Michael Dunne

(Dr. Michael Dunne M.D.)

Currently holds a position at Iterum Therapeutics PLC

Positions

Position Company Period
Chief Scientific Officer Iterum Therapeutics PLC Nov. 1, 2015 -
Michael Dunne's trades of Iterum Therapeutics PLC's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-12-27 2023-12-22
B Purchase
25,000 +28.2%
1.40
USD 35,000 		25,000 +28.2% 1.40 USD 35,000
2023-12-19 2023-12-18
B Purchase
10,000 +12.7%
1.84
USD 18,442 		10,000 +12.7% 1.84 USD 18,442
2023-11-27 2023-11-22
B Purchase
20,000 +34.0%
2.03
USD 40,690 		20,000 +34.0% 2.03 USD 40,690
2022-09-09 2022-09-07
B Purchase
10,000 +39.1%
2.22
USD 22,200 		10,000 +39.1% 2.22 USD 22,200
2021-01-27 2021-01-26
S Sale
33,143 -11.4%
1.73
USD 57,337 		33,143 -11.4% 1.73 USD 57,337
2020-10-28 2020-10-27
B Purchase
61,540
0.00
USD 0 		61,540 0.00 USD 0
// ... existing code ... // ... rest of the file ...